Aurora Biosciences (ABSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aurora Biosciences (ABSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Boyce Burge who wrote (14)	9/26/1997 8:08:00 PM
From: James Silverman	of 359

Actually Boyce, my remaining shares are at an average of about $10 bucks. I took some profits into the H&Q aftermath rally. As you could expect, H&Q tends to highlight a few biotechs in particular. Last H&Q: ARQL, SANG and I believe MATK were highlighted in particular. Perhaps this year it will be ABSC-were they a big underwriter? The unfolding of ARQL's business plan hasn't dissappointed me in the least, its been brilliant to date, with the one sputter resulting from a secondary offering. ABSC has had a similarly impressive business plan begin to take form. So I guess you are saying the time to buy is in November-December before the conference and the late Spring after the shine dulls down a bit :-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next